[医疗瘤治疗头癌:在标准化和个性化之间]
Simon Laban1,2
1Klinik für Hals-Nasen-Ohrenheilkunde und Kopf-Halschirurgie, Universitätsklinik Ulm, Ulm, Deutschland. simon.laban@uniklinik-ulm.de.
HNO
|April 22, 2025
概括
头癌治疗的新批准,包括PD1/PD-L1轴抑制剂,正在改变息护理标准. 生物标志物和新辅助免疫疗法整合被讨论为个性化治疗策略.
科学领域:
- 在瘤学瘤学.
- 癌症治疗 癌症治疗
- 免疫治疗是一种免疫疗法.
背景情况:
- 针对头部和部瘤的全身癌症疗法随着新药的批准而发展.
- 治疗的标准化和个性化在临床决策中构成了挑战.
- 除了临床因素外,分子生物标志物越来越重要.
研究的目的:
- 总结一下最近在头癌系统治疗方面的进展.
- 讨论分子生物标志物和免疫治疗在治疗方案中的整合.
- 探索平衡标准化和个性化癌症护理的策略.
主要方法:
- 对涉及PD1/PD-L1轴抑制剂的随机III期研究的综述.
- 对新辅助药KEYNOTE-689试验数据的分析.
- 讨论临床试验结果及其对日常实践的影响.
主要成果:
- 新的批准改变了治疗标准,特别是在息环境中.
- 与化学辐射相结合的PD1/PD-L1轴抑制剂显示出有希望的结果.
- 来自KEYNOTE-689试验的积极结果表明了新辅助免疫疗法的潜力.
结论:
- 由于新的批准和生物标志物,头瘤的治疗标准正在发生变化.
- 将新辅助免疫疗法纳入临床常规是未来发展的关键领域.
- 个性化治疗策略正在出现,平衡标准化与个体患者需求.
更多相关视频
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K


